Multiple Sclerosis: CIS, RRMS, and SPMS
Intervontions of Interest: Monoclonal Antibodies natalizumab (Tysabri®, Biogen) ofatumumab (Kesimpta®, Novartis) ocrelizumab (Ocrevus®, Genentech) rituximab (Rituxan®, Genentech, and biosimilars) ublituximab (TG Therapeutics) Oral Therapies dimethyl fumarate (Tecfidera®, Biogen, and generics) diroximel fumarate (Vumerity®, Biogen) monomethyl fumarate (Bafiertam®, Banner Life Sciences) fingolimod (Gilenya®, Novartis) ozanimod (Zeposia®, Bristol Myers Squibb) ponesimod (Ponvory®, Janssen) siponimod (Mayzent®, Novartis) teriflunomide […]
Recent Comments